The strychnine-sensitive glycine receptor (GlyR) mediates inhibitory synaptic transmission in the spinal cord and brainstem and is linked to neurological disorders, including autism and hyperekplexia. Understanding of molecular mechanisms and pharmacology of glycine receptors has been hindered...
Finally, ivermectin has long been known to displace [3H]strychnine in radiolabeled binding studies, implying that it may exert some effect on the GlyR. Indeed, ivermectin has recently been demonstrated to act as a use-dependent inhibitor of a GlyR that is endogenously expressed in primary cultured rat cortical neurons.
Mijn conclusie: IVM/AVM werken inderdaad tegen autisme.